Veeva Systems
As the sun sets on the final quarter of the 2026 fiscal year, Veeva Systems (NYSE: VEEV) has once again proven its mettle in the volatile world of vertical software. Reporting its Q4 results on March 4, 2026, the life sciences cloud leader posted revenue of $810 million, hitting the
Thermo Fisher Scientific
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the life sciences sector. Reporting its fourth-quarter 2025 results on January 29, 2026, the company delivered a
Life Sciences
The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged by a staggering 82% over the past year. This "Great Rebound," fueled by a record-shattering $240 billion in total M&A investment in 2025, represents a fundamental
M&A
As of January 26, 2026, the American corporate landscape is undergoing its most radical transformation in a generation. Following a two-year period of high-interest-rate hibernation, the United States merger and acquisition (M&A) market has roared back to life with a ferocity that has caught even seasoned Wall Street
Agilent Technologies
SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has declared a quarterly dividend of 25.5 cents per share of common stock. This latest declaration underscores the company'
IIPR
Innovative Industrial Properties (NYSE: IIPR), a leading real estate investment trust (REIT) focused on the regulated cannabis industry, has reported a robust third-quarter 2025 performance, exceeding market expectations for both revenue and Normalized Funds From Operations (FFO) per share. The company announced Q3 2025 total revenues of $64.7 million,
Avantor
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, saw its shares tumble by a staggering 17.4% on Wednesday, October 29, 2025. The precipitous decline followed the release of its
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent strategic developments. This significant uptick reflects investor confidence in the life sciences giant's aggressive expansion into
TSX
As October 2025 unfolds, the Canadian financial landscape presents a dynamic environment for investors willing to explore the high-risk, high-reward world of penny stocks on the Toronto Stock Exchange (TSX) and TSX Venture Exchange. While inherently speculative and volatile, these small-cap equities can offer significant upside potential for those who
Agilent
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE). This surge, echoing similar positive movements for other life sciences companies like
Avantor
Avantor (NYSE: AVTR) is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology industries. Headquartered in Radnor, Pennsylvania, the company plays a pivotal role in supporting scientific innovation across diverse sectors, from biopharmaceuticals and healthcare to education and government. Avantor'
Avantor
Avantor (NYSE: AVTR) shares have recently experienced a significant and sustained plunge, hitting a 52-week low and reflecting a challenging period for the life sciences company. This sharp decline is a direct consequence of both a widespread market sell-off and a confluence of company-specific issues, sending ripples of concern through